Literature DB >> 3882140

Investigations of host defence in patients with sickle cell disease.

S H Boghossian, G Wright, A D Webster, A W Segal.   

Abstract

Parameters of host defence were investigated in 30 patients with sickle cell disease (SCD). A newly devised perfusion system was used to study the kinetics in whole blood of leucocyte adherence, phagocytosis, killing and solubilization of a mixture of Staph. aureus and Str. pneumoniae, and secretion of lactoferrin. A skin window technique was used to examine the accumulation of leucocytes at inflammatory foci and their subsequent rate of movement through a filter. Serum concentrations of C3, C4, total haemolytic complement and immunoglobulins were also measured. The rate of neutrophil migration into filters was slightly reduced in patients with SCD. The proportion of monocytes that emigrated from the skin windows and their rate of migration were markedly diminished. The adhesion of neutrophils and their ability to kill staphylococci were also reduced, particularly in patients of the haemoglobin (Hb) SS and Hb S-beta-thalassaemia genotypes. Neutrophil function was mostly impaired in patients with the greatest frequency of bacterial infection. The rate of clearance of pneumococci was related to the concentration of type specific immunoglobulin G but not M. Serum concentrations of immunoglobulins and complement were normal. We were unable to define a defect of host defence of sufficient magnitude to explain the susceptibility of these patients to severe infection.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882140     DOI: 10.1111/j.1365-2141.1985.tb07339.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  In vivo production of type 1 cytokines in healthy sickle cell disease patients.

Authors:  S C Taylor; S J Shacks; Z Qu
Journal:  J Natl Med Assoc       Date:  1999-11       Impact factor: 1.798

2.  Type 2 cytokine serum levels in healthy sickle cell disease patients.

Authors:  S C Taylor; S J Shacks; Z Qu; P Wiley
Journal:  J Natl Med Assoc       Date:  1997-11       Impact factor: 1.798

3.  Neutrophil chemotaxis in sickle cell anaemia, sickle cell beta zero thalassaemia, and after splenectomy.

Authors:  E A Donadi; R P Falcão
Journal:  J Clin Pathol       Date:  1987-06       Impact factor: 3.411

4.  Transport proteins and acute phase reactant proteins in children with sickle cell anemia.

Authors:  R P Warrier; S Kuvibidila; L Gordon; J Humbert
Journal:  J Natl Med Assoc       Date:  1994-01       Impact factor: 1.798

5.  Combined effects of in vitro penicillin and sickle cell disease sera on normal lymphocyte functions.

Authors:  Stephen C Taylor; Samuel J Shacks; Zengwei Qu; Psyhra Bryant
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

6.  Impact of Mannose-Binding Protein Gene Polymorphisms in Omani Sickle Cell Disease Patients.

Authors:  Mathew Zachariah; Shoaib Al Zadjali; Wafa Bashir; Rahma Al Ambusaidi; Rhea Misquith; Yasser Wali; Anil Pathare
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-02-15       Impact factor: 2.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.